Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | GFER | P55789 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | ELANE | P08246 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MITF | O75030 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.42 |
| ▸ | JAK2 | O60674 | 1/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11401003 | 0.84 | ELANE (0.49) | LMNAL3MBTL1KDM4EGFERCYP1A2 | |
| SCHEMBL6593684 | 0.84 | CYP1A2 (0.50) | LMNAL3MBTL1KDM4EGFERCYP1A2 | |
| SCHEMBL29923741 | 0.81 | ALDH1A1 (0.55) | KDM4ECYP1A2HTTSMN1; SMN2MAPT | |
| SCHEMBL4748554 | 0.81 | POLB (0.53) | LMNAL3MBTL1KDM4EHTTSMN1; SMN2 | |
| SCHEMBL3390039 | 0.81 | NQO2 (0.53) | LMNAL3MBTL1KDM4ECYP1A2SMN1; SMN2 | |
| SCHEMBL3906125 | 0.81 | GAA (0.47) | LMNAKDM4ECYP1A2ALDH1A1GAA | |
| SCHEMBL4966064 | 0.81 | ALDH1A1 (0.55) | KDM4ECYP1A2HTTSMN1; SMN2MAPT | |
| SCHEMBL3642253 | 0.81 | LMNA (0.41) | LMNAL3MBTL1KDM4EGFERCYP1A2 | |
| SCHEMBL8134109 | 0.81 | LMNA (0.53) | LMNAL3MBTL1KDM4ECYP1A2ELANE | |
| SCHEMBL11399020 | 0.81 | BACE1 (0.52) | LMNAKDM4ECYP1A2HTTELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0124752-B1 | MIXTURES OF SUBSTANCES WITH GROWTH AND OUTPUT ACCELERATING EFFECT AS WELL AS FEED AND WATERING LIQUIDS WHICH CONTAIN LOW AMOUNTS OF THESE MIXTURES | BASF Aktiengesellschaft (DE) | 1986-07-16 | — | — | EP | claimed |
| EP-0065192-B1 | GROWTH-PROMOTING FODDER OR DRINKING LIQUID | BASF Aktiengesellschaft (DE) | 1984-02-01 | — | — | EP | claimed |
| US-20100305326-A1 | Chemical Fragment Screening and Assembly Utilizing Common Chemistry for NMR Probe Introduction and Fragment Linkage | MARQUETTE UNIVERSITY (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100305326-A1 | Chemical Fragment Screening and Assembly Utilizing Common Chemistry for NMR Probe Introduction and Fragment Linkage | MARQUETTE UNIVERSITY (US) | 2010-12-02 | — | — | US | disclosed |
| US-20100305326-A1 | Chemical Fragment Screening and Assembly Utilizing Common Chemistry for NMR Probe Introduction and Fragment Linkage | MARQUETTE UNIVERSITY (US) | 2010-12-02 | — | — | US | disclosed |
| EP-0113432-B1 | CHLOROMETHYL QUINOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE | ALKALOIDA VEGYéSZETI GYáR (HU) | 1993-03-17 | — | — | EP | disclosed |
| US-4632983-A | Pyridone dyes containing a oxydiazone substituent | BASF AKTIENGESELLSCHAFT (DE) | 1986-12-30 | — | — | US | disclosed |
| US-4599345-A | BACTERICIDES, FUNGICIDES ANTIINFLAMMATORY | ALKALOIDE VEGYESZETI GYAR (HU) | 1986-07-08 | — | — | US | disclosed |
| EP-0113432-A1 | Chloromethyl quinoline derivatives, process for their preparation and their use | ALKALOIDA VEGYéSZETI GYáR (HU) | 1984-07-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305326-A1 | Chemical Fragment Screening and Assembly Utilizing Common Chemistry for NMR Probe Introduction and Fragment Linkage | CYFIP2, RPS27A, FRS2 | LMNA 2178/4885L3MBTL1 3503/4885KDM4E 4552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.